Protection may also be influenced by the cell type and method (infection or transfection) used to produce the challenge virus, by selection for truncation of the cytoplasmic tail of Env, and by the heterogeneous neutralization sensitivity of the polyclonal challenge virus (43, –, 46). This evidence concerns the gene ERVW-1 and infection.